References
Bagge U., Branemark P., & Skalak R., (1981). Measurement and Influence of White Cell deformability. In Lowe, G., Barbenel, C., Forbes, D., Clinical Aspects of Blood Viscosity and Cell Deform ability, Spring-Verlag Berling Heidelberg, 27-36. Barnes, A., 1981. Blood Viscosity in Diabetes Mellitus. In Lowe, G., Barbenel, C., Forbes, D., Clinical Aspects of Blood Viscosity and Cell Deformability, Spring-Verlag Berling Heidelberg, 151-162 Barzilay J. I., Abraham L., Heckbert S. R, et al. (2001). The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes.50:2384–2389. Blüher M., Bashan N., & Shai I, et al. (2009). Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body insulin sensitivity. J Clin Endocrinol Metab. 94:2507–2515 Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. Int J Mol Sci. 2022 Mar 26;23(7):3636. doi: 10.3390/ijms23073636. PMID: 35408994; PMCID: PMC8998851 Calle M. C., & Fernandez M. L. (2012) Inflammation and type 2 diabetes. Diabetes Metab. 38(3): 183-91. Cataudella E., Giraffa C.M., Di Marca S., Pulvirenti A., Alaimo S., Pisano M., Terranova V., Corriere T., Ronsisvalle M.L., Di Quattro R., et al. Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia. J. Am. Geriatr. Soc. 2017;65:1796–1801. doi: 10.1111/jgs.14894. Chang A. M., & Halter J. B. A. (2003). Aging and insulin secrection. J Physiol Endocrinol Metebol. 284:E7–12. Cheesbrough M. District ¬Laboratory Practice in Tropical Countries. Cambridge, UK: Cambridge University Press.2006, pp: 320-3 Chen H. L., Wu C., Cao L., Wang R., Zhang T. Y, He Z. (2024). The association between the neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord. 24(1):107. Chung F. M., Tsai J. C. R., Chang D. M., Shin S. J., Lee Y. J., (2005). the Fu-mei Chung. . Peripheral Total and Differential Leukocyte Count in Diabetic Nephropathy. Diabetes Care 28(7): 1710-1717 Dehghan A., Kardys I., de Maat MP, et al. (2007). Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes. 56:872–878. De Jager C.P., Van Wijk P.T., Mathoera R.B., De Jongh-Leuvenink J., Van Der Poll T., Wever P.C. (2010). Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit. Care. 14:R192. doi: 10.1186/cc9309. Devi A., Thielemans L., Ladikou E. E., Nandra T. K., Chevassut T. (2022). Lymphocytosis and chronic lymphocytic leukaemia: investigation and management. Clinical Medicine. 22(3):225-9. Donath M. Y., & Shoelson S. E. (2011). Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 11(2): 98-107. Duncan B. B, Schmidt M. I. & Pankow J. S. et al. (2003). Atherosclerosis Risk in Communities Study Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes. 52:1799–1805. Festa A., D’Agostino R, Jr., Tracy R. P., & Haffner S. M. (2002). Insulin Resistance Atherosclerosis Study Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 51:1131–1137. Geert W. S. S., (2008). Cell activation in the circulation: The auto-digestion hypothesis. In Chien, Shu, Chen, P. C. Y., Fung, Y. C., An Introductory Text to Bioengineering. Word Scientific, Singapore, 131-14 Getawa S., & Adane T. (2022). Hematological abnormalities among adults with type 1 diabetes mellitus at the University of Gondar Comprehensive Specialized Hospital. SAGE Open Med. 10:20503121221094212. doi: 10.1177/20503121221094212. Goldbach-Mansky R. (2009). Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci 1182:111–123. Granger D. N., & Senchenkova E. (2010). "Leukocyte–Endothelial Cell Adhesion". Inflammation and the Microcirculation. Integrated Systems Physiology—From Cell to Function. Vol. 2. Morgan & Claypool Life Sciences. pp. 1–87. Han C., Robinson D. W. Jr., Hackett M. V., Paramore L. C., Fraeman K. H., Bala M. V. (2006). Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 33:2167–2172. Jones R. L., & Peterson C. M. (1981). Hematologic alterations in diabetes mellitus. The American Journal of Medicine 1981; 70(2): 339-352. Kostova V., Antonova N., Chaushev N., Velcheva I., Ivanov I., (2015). Relationship between the rheological properties of the blood and changes of oscillations in skin temperature after cold test in patients with type 2 diabetes mellitus. Series on Biomechanics 29, 1, 11-16. Lee J., Patel D., Park S. (2011). Local Rheology of Human Neutrophils Investigated Using Atomic Force Microscopy. Int. J. Biol. Sci. 7,1, 102-111 Liu S., Wang X., She F., Zhang W., Liu H., Zhao X. (2021). Effects of Neutrophil-to-Lymphocyte Ratio Combined with Interleukin-6 in Predicting 28-Day Mortality in Patients with Sepsis. Front. Immunol. 12:639735. doi: 10.3389/fimmu.2021.639735. McEver R. P. (2005). Molecular and Cellular Contributions to Selectin-Dependent Leukocyte Adhesion Under Flow. In Hamann, Alf, Engelhardt, Br., Leukocyte Trafficking. WILEY- VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 219-247. Medugu J.T.1., Bukar A.1., Obi S.O.1, Waziri G.1., Buhari A.1., Ferdinand I.M., Nasir I.A., Dangana A., Momodu I., Wankari W., Wakbe J.K.1 Balami P.D. (2025). Neutrophil-to- Lymphocyte and Platelet-to-Lymphocyte Ratios as Inflammatory Biomarkers in Type-2 Diabetes Mellitus: A Cross-sectional Study in Maiduguri, Nigeria. (2025). Sokoto Journal of Medical Laboratory Science, 10(2). https://doi.org/10.4314/ Medzhitov R. (2008). "Origin and physiological roles of inflammation". Nature. 454 (7203): 428–435. Nakanishi S., Yamane K., Kamei N., Okubo M., Kohno N. (2003.) Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 26:2754–2757. Ohshita K., Yamane K., Hanafusa M., Mori H., Mito K., Okubo M., Kohno N. (2004). Elevated white blood cell count in subjects with impaired glucose tolerance. Diabetes Care. 27(2): 491-496. Rozenberg G, Microscopic haematology: a practical guide for the laboratory, 3rd edn. Elsevier Australia; 2011. Schmidt M. I., Duncan B. B., Sharrett A. R., et al. (1999). Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 353:1649–1652. Shah M, Haseena K, Kainat S, et al. Morphological Study of Human Blood for Different Diseases. J Sci. & Tech. Res. 2020; 30: 23047- 57. . Solomon D. H., Love T. J., Canning C., & Schneeweiss S. (2010). Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis. 69:2114–2117. Stoltz J.F., Singh M.,& Riha, P., (1999). Rheology of Leukocytes. In Stoltz, J.-F., Singh, M., Riha, P., Hemorheology in Practice. IOS Press, Netherlands, 36-48. Strati P., & Shanafelt T. D. (2015). Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood. 126(4):454-62. Sukrisman L., Sinto R., Priantono D. (2021) Hematologic Profiles and Correlation Between Absolute Lymphocyte Count and Neutrophil/Lymphocyte Ratio with Markers of Inflammation of COVID-19 in an Indonesian National Referral Hospital. Int J Gen Med. 14:6919-6924 https://doi.org/10.2147/IJGM.S337440 Tran-Son-Tay, R., Nash, G. B.